Cargando…
CD24(+)/CD38(-) as new prognostic marker for non-small cell lung cancer
BACKGROUND: Lung cancer is the leading cause of death among cancers in the world. The annual death toll due to this disease exceeds the combined deaths caused by colon, breast, prostate, and pancreatic cancers. As a result, there has been a tremendous effort to identify new biomarkers for early dete...
Autores principales: | Karimi-Busheri, Feridoun, Rasouli-Nia, Aghdass, Zadorozhny, Victoria, Fakhrai, Habib |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3844723/ https://www.ncbi.nlm.nih.gov/pubmed/24094028 http://dx.doi.org/10.1186/2049-6958-8-65 |
Ejemplares similares
-
Molecular integrity and global gene expression of breast and lung cancer stem cells under long-term storage and recovery
por: Karimi-Busheri, Feridoun, et al.
Publicado: (2012) -
Senescence evasion by MCF-7 human breast tumor-initiating cells
por: Karimi-Busheri, Feridoun, et al.
Publicado: (2010) -
Cell Proliferation, Viability, Differentiation, and Apoptosis of Iron Oxide Labeled Stem Cells Transfected with Lipofectamine Assessed by MRI
por: Jalli, Reza, et al.
Publicado: (2023) -
CD24 Expression is an Independent Prognostic Marker in Cholangiocarcinoma
por: Agrawal, Shefali, et al.
Publicado: (2007) -
The pathogenic relevance of the prognostic markers CD38 and CD49d in chronic lymphocytic leukemia
por: Brachtl, Gabriele, et al.
Publicado: (2013)